Skip to main content

Table 2 Basal and final results and differences between the groups (intervention and control)

From: Impact of the CareWell integrated care model for older patients with multimorbidity: a quasi-experimental controlled study in the Basque Country

  Intervention Control β (95% CI) p-value
Sample size 86 89   
BMI     0.047
 Basal 31.4 (5.7) 29.2 (5.3)  
 Final 30.6 (5.7)a 29.1 (5.4) −0.5 (−1.1,-0.01)  
Heart rate     0.378
 Basal 73.4 (11) 71.4 (11.4)  
 Final 73.4 (12) 70.6 (12.2) 1.4 (− 1.8,4.6)  
Systolic blood pressure     0.046
 Basal 132.3 (15) 138.1 (17)  
 Final 127.5 (16)a 133.9 (16)a −4.7 (−9.3,-0.1)  
Diastolic blood pressure     0.175
 Basal 71.5 (9.4) 71.6 (10.1)  
 Final 70 (9.6) 71.1 (11.1) −1.9 (−4.8,0.9)  
Oxygen saturation     0.014
 Basal 95.9 (2.1) 96 (2.1)  
 Final 95.9 (2) 96.2 (2.3) −0.9 (−1.6,-0.2)  
Blood glucose     0.049
 Basal 120.5 (42) 127.7 (42)  
 Final 112 (31)a 125.5 (47) −12.6 (−25.2,-0.02)  
HbA1c     0.060
 Basal 6.7 (1.2) 6.8 (1.1)  
 Final 6.6 (1.1) 6.9 (1.3) −0.33 (−0.7,0.01)  
Creatinine     0.309
 Basal 1.2 (0.6) 1.2 (0.5)  
 Final 1.3 (0.8)a 1.3 (0.6)a 0.05 (−0.1,0.04)  
Barthel index     0.561
 Basal 89.5 (18.9) 88.2 (18.4)  
 Final 86.9 (20.8)a 85.1 (20)a 1.0 (−2.5,4.6)  
Depression-GDS     0.656
 Basal 3.3 (2.7) 4.7 (3.4)  
 Final 3.2 (3) 4.3 (3.5) −0.2 (−1.0,0.6)  
  1. Data presented as mean, standard deviation or their corresponding 95% confidence interval (95% CI). a indicates pre–post differences within each group (intervention or control). BMI, body mass index; GDS, Geriatric Depression Scale, short form; β, beta coefficient of the intervention group, estimated from the regression model. Models were adjusted by baseline values of the specific outcome, baseline BMI value, follow-up period, age, gender and age-adjusted Charlson Comorbidity Index